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Abstract
Background: Living with a chronic disease often means experiencing chronic treatments and regular multidisciplinary
monitoring as well as a profound life-changing experience which may impact all aspects of a patients life. The patient
experience of chronic disease is frequently assessed by patient reported measures (PRMs) which incorporate patients
perspectives to better understand how illness, treatment and care impact the entirety of a patient’s life. The purpose of
this review was to collect and review different kinds of available PRM instruments validated for chronic patients,
to produce an inventory of explored concepts in these questionnaires and to identify and classify all dimensions
assessing chronic patients experience.
Methods: A systematic review of PRM instruments validated for chronic patients was conducted from three databases
(Medline, the Cochrane library, and Psycinfo). Articles were selected after a double reading and questionnaires
were classified according to their targeted concept. Then, all dimensions of the questionnaires were clustered
into different categories.
Results: 107 primary validation studies of PRM questionnaires were selected. Five kinds of instruments were recorded:
1) Questionnaires assessing health related quality of life or quality of life; 2) Instruments focusing on symptoms and
functional status; 3) Instruments exploring patients’ feelings and attitude about illness; 4) Questionnaires related
to patients’ experience of treatment or healthcare; 5) Instruments assessing patients attitudes about treatment
or healthcare. Twelve categories of dimensions were obtained from these instruments.
Conclusions: This review provided an overview of some of the dimensions used to explore chronic patient experience.
A large PRM diversity exists and none of the reviewed and selected questionnaires covered all identified categories of
dimensions of patient experience of chronic disease. Furthermore, the definition of explored concepts varies
widely among researchers and complex concepts often lack a clear definition in the reviewed articles. Before
attempting to measure chronic patient experience, researchers should construct appropriate instruments focusing on
well-defined concepts and dimensions encompassing patient’s personal experience, attitude and adaptation to illness,
treatment or healthcare.
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Background
Over the past two decades, greater recognition of pa-
tients’ point of view has been facilitated by patient re-
ported measures (PRMs) which are directly reported by
the patient without interpretation of their responses by a
clinician or anyone else [1]. Patient reported experience
measures (PREMs) are a class of PRMs used to capture
patient experience of health care or health service [2]. If
increased attention has been paid to the measurement of
“patient experience” as a quality indicator of patient care
and safety for accreditation [3, 4], there has also been a
rapid expansion in the use of the term “patient experi-
ence” in the area of clinical practice and research [3].
The need for a patient-centered approach has been rec-
ognized for assessment of the impact of disease and
treatment in a patients life. Patient reported outcome
measures (PROMs) is a broad family of measures con-
sisting of a direct report by the patient of health out-
comes associated with illness or treatment. PROMs
include assessment of symptoms, functional status,
health-related quality of life (HRQOL), satisfaction and
adherence to medication, and various psychological,
physical, social aspects [4–6]. PREMs and PROMs are
currently distinguished in the literature since the devel-
opment and use of measures of patient reported experi-
ences have often been carried out in isolation from work
on patient reported outcomes [7]. In the field of chronic
disease, patient experience often includes experience of
chronic treatments, health practices and regular multi-
disciplinary monitoring as well as a profound life-changing
experience which may impact all aspects of a patients life,
inside and outside of care. The umbrella term “patient ex-
perience” for chronic diseases is somewhat confusing, and
should therefore not be limited to patient healthcare experi-
ence as both PREMs and PROMs are of interest. Even if it
appears that each class of PRMs overlap with the other,
each one does not capture the whole complexity of chronic
patient experience with chronic disease [7]. Therefore,
chronic patient experience should simultaneously take into
consideration PREMs, providing insight into the patient ex-
perience with their care or health services, and PROMs,
pertaining to patient’s health, quality of life, or functional
status associated with illness or treatment.
A fundamental consideration in the development of an
instrument assessing PRM is the definition of the con-
cept to be measured with domains that must be ex-
plored. As mentioned by the Cochrane Handbook for
Systematic Reviews of Interventions: “Concepts may re-
late to an individual item or to a subset of items that
refer to the same concept, often referred to as domains.
For example, an item assessing difficulty walking up
stairs would be a concept related to physical functioning
and might be labelled walking up stairs or as part of
physical function” [8]. So a domain could be seen as a
concept component or a sub-part of a concept. A di-
mension is an item or a subset of items that explores a
domain. For example, health-related quality of life is a
multidimensional concept. This concept is traditionally
composed of several domains including the social do-
main, which could be explored by different dimensions
like “activities” or “family” dimensions. Currently, con-
cepts and domains that should be explored to capture
chronic patient experience remains to be identified. A
first step in adequately conceptualizing chronic patient
experience is to identify all essential core concepts and
components that are currently measured with existing
PRMs for chronic patients. This critical step could help
researchers that would wish to evaluate full or partly pa-
tient experience of chronic disease. It can be valuable in
different manners: draw a picture of concepts and do-
mains related to patient experience in chronic illness,
identification of lack of evaluation of some domains and
development of new questionnaires filling this lack, and
avoid development of new questionnaires if question-
naires assessing the same concepts already exist. The
purpose of this review was to collect and explore patient
reported measures (PROMs or PREMs) instruments, val-
idated for a specific chronic disease or for any chronic
patients, to produce an inventory of concepts explored
inside these questionnaires, and to identify all categories
of dimensions that allow capturing global chronic pa-
tient experience.
Methods
Following recommendations published by Moher and al.
[9], a systematic review of PRM instruments validated for
chronic patients was conducted from November 2016 to
December 2016, on articles published until November
2016. No starting date has been specified to avoid missing
some primary validation studies of questionnaires. It com-
prised three stages consisting of: 1) Search strategy: identi-
fication of articles by specifying inclusion and exclusion
criteria, keywords and search strings in the databases, 2)
Selection: article pre-selection by reading titles, followed
by a selection by reading abstracts and full-text, 3) Extrac-
tion: extraction of data from articles, filling in a reading
grid and providing a synthesis.
Stage 1: Search strategy
Relevant articles were searched from three databases
likely to deal with PRM (Medline, the Cochrane library,
and Psycinfo). Because the use of searchable technical
terms for indexing international literature in databases is
not always up-to-date, the search strategy was composed
of free text terms, synonyms, and MeSH terms. Before
building the search, some well-known concepts in PRM
were defined by consensus between the authors based
on the literature. As PROMs was not a Mesh term in
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2016, other MeSH terms and free text terms dealing
with PROMs concepts (“Patient Outcome Assessment”,
“Quality of life” (QOL), “Health Related Quality Of Life”
(HRQOL), “Attitude to Health”, “Illness Behavior”, “Ac-
tivities of Daily Living”…) were included into the search
equation [see Additional file 1]. PREMs’ terms, often
approached by the “patient centered care” expression
[10] and used to capture the overall patient experience
of health care or health service were also added to the
search equation, such as the “patients’ satisfaction”
MeSH term. This last term appeared to be a distinct but
important PRM concept with a predominantly affective
judgment formed by the patient [11].
In brief, the search string subsumes five blocks: the
first one related to chronic patients, the second one re-
lated to the different kinds of PRMs concepts identified,
the third related to measurement instruments, the
fourth related to the primary validation study and the
last one indicating exclusion criteria. The primary inclu-
sion and exclusion criteria are shown in Table 1. Because
the focus was on the primary validation of question-
naires, studies that reported translation and transcultural
validation, revised scale validation, scale revalidation or
only scale use were excluded. The focus was on adults
with chronic diseases, defined as diseases of long dur-
ation and generally slow progression according to the
World Health Organization [12]). Questionnaires for the
patient’s family (including proxy instruments) were ex-
cluded as well as instruments for children, for patients
with acute disease, or patients with psychiatric disease.
Stage 2: Article selection
To select articles, a first author reviewed the titles of all
records retrieved from the initial search. Then a second
and a third author performed an independent review of
the same articles by sharing the full list of titles. There
were two kinds of disagreements: those related to inclu-
sion or exclusion of articles and those related to the rea-
son for exclusion. The two reviewers in question resolved
the disagreement by mutual agreement after referring to
the abstract. Once articles were selected by title, the same
procedure was used to score the available abstracts and
full-text articles, using the same article selection and dis-
agreement resolution process.
Stage 3: Data extraction
Data from selected articles were extracted and uploaded
to a reading grid to classify the different questionnaires
and their dimensions. Articles original objective (targeted
concept), targeted population, questionnaires’ dimensions,
language, name and year of publication were collected. To
begin, all selected questionnaires were classified into dif-
ferent groups according to the targeted concept men-
tioned initially by the authors of each validation article.
Once the questionnaires were classified according to their
targeted concepts, their dimensions were sorted into dif-
ferent categories. The names of the dimensions were also
based on report of the original authors, whereas dimen-
sions classification (categories of dimensions) has been
created by authors of the systematic review according to
the description of these dimensions and the content of
their items when they were detailed. Once again the two
reviewers in question resolved the disagreement by mutual
agreement if necessary.
Given the broad family of measures in PROMs, differ-
ent categories of dimensions were expected based on
HRQOL, functional status, and patient experience of
treatment. HRQOL is mainly defined as “the assessment
of the impact of disease and treatment across the phys-
ical, psychological, social, and somatic domains of func-
tioning and well-being” [13]. Given this, “physical”
(physical symptoms, pain or discomfort), “psychological”
(feelings and self-esteem), and “social” (social environ-
ment, activities, relationships and support) categories of
dimensions were expected. A “functional” dimension
category (including mobility, dependence, work capacity
and impact on activities of daily living) was also added
for questionnaires exploring functional status which is
defined as “an individual’s effective performance of or
ability to perform those roles, tasks, or activities that
Table 1 Article eligibility criteria
Inclusion criteria: Exclusion criteria:
- Full text original article
- Questionnaire for patients with chronic disease
- Questionnaire to measure patient reported outcomes (PROMs),
patient reported experiences (PREMs) or patient satisfaction
- Report of a scale construction, evaluation and validation of
psychometric properties (primary study)
- Published in English or French
- Published until November 2016
- Questionnaires to evaluate a patient with acute or
psychiatric disease
- Questionnaires to evaluate children or a patients family
- Short or revised form of a scale (including additional modules)
- Transcultural adaptation or translation validation studies
- Scale revalidation on another sample or deepening of scale
psychometric properties
- Articles exclusively related to content and face validation
- Studies using a scale without performing any validation
- Comparisons of scale psychometric properties
- Scale systematic review articles
- Instruments with a predominantly diagnostic, screening,
prognostic or utility purpose
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are valued (e.g. going to work, playing sports, or main-
taining the house)” [1]. Two categories of dimensions
called “effects of treatment” (benefic or side effects) and
“expectations and satisfaction with treatment” dimen-
sions were expected for questionnaires focusing on pa-
tient experience of treatment. Finally, a last category of
dimensions more related to PREMs and called “experi-
ence of healthcare” (including involvement in decisions
and respect for preferences, accessibility and continuity
of care, physicians communication, support and trust)
was created, bringing a total of seven initial potential
categories of dimensions. New categories of dimensions
could be added if they have not been considered ahead
of the reading grid development. At the end, categories
which were similar enough were merged. In theory, a di-
mension explores a particular domain, but in practice this
was not necessarily the case. Several questionnaires were
composed of composite dimensions dealing with several
domains. As a consequence, we have been forced to classify
certain dimensions into several categories of dimensions if
appropriate (for example, a dimension called “physical
symptoms and everyday living” could be classified both in
“physical” and in “functional” categories of dimensions).
Statistical analysis
To evaluate whether the reviewers agreed with each
other, Kappa coefficients were computed. This allowed
to estimate consistency related to inclusion and exclu-
sion of articles at each selection step [14]. Descriptive
statistical analyses (medians, quartiles, minimum, max-
imum and frequencies) for the main variables of the
extraction reading grid were performed. The analysis
was performed using software R 2.12.1.
Results
Selection and description of articles
Figure 1 lists the process of literature identification, screen-
ing for eligibility, and selection of studies during the litera-
ture search presented in a Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) flow
diagram [9]. The search string identified a total of 2923
potentially relevant articles that met the search criteria in
64 articles consecutively excluded with :
• 7 : Not PRM instrument
• 4 : Not validation study
• 31 : Not primary validation
• 3 : Not target patient
• 19 : Other
1956 articles consecutively excluded with :
• 926 : Not PRM instrument
• 619 : Not validation study
• 174 : Not primary validation
• 90 : Not target patient
• 147 : Language
2923 records identified through 
database searching :
• Pubmed : 1878
• The Cochrane Library : 411
• Psycinfo : 634
548 duplicated articles
Articles screened by title
N=2375
Articles screened by abstract
N=419
Articles screened by full text
N=171
248 articles consecutively excluded with :
• 43 : Not PRM instrument 
• 102 : Not validation study
• 95 : Not primary validation
• 6 : Not target patient
• 2 : Language
107 articles
Fig. 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the selection process. Not PRM instrument:
Articles which don’t deal with a patient reported measure (PRM) (including studies with proxy instrument or questionnaire to assess family experience
or healthy people point of view on illness); Not validation study: Studies using PRM without performing any validation (including comparisons of
scale psychometric properties or scale systematic review articles); Not primary validation: Short or revised form of a PRM, transcultural adaptation or
translation validation studies, scale revalidation on another sample or deepening of scale psychometric properties, and articles exclusively related to
content and face validation; Not target patient: questionnaires to evaluate children or patient with acute or psychiatric disease; Language: Articles
not published in English or French; Other: Unavailable articles or questionnaire’s dimensions not mentioned in full text
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the three bibliographic databases. After the removal of du-
plicates (n = 548) the title content of 2375 studies pub-
lished from 1976 to 2016 was reviewed for eligibility. After
the pre-selection step including assessment of abstracts
(n = 419) and full-text articles (n = 171), 107 studies that
investigated the measurement properties of instruments
related to patient experience in chronic illness were
selected. Kappa coefficients between authors during the
different selection process ranged from 0.79 to 0.88.
The earliest retained study of the review was published
in 1980 and the latest in 2016. The median year of publi-
cation was 2005, with a first quartile year of 2000 and a
third quartile year of 2010.
The target population of the final selected question-
naires was patients with various chronic illnesses in
19.6% of the cases (n = 21). These 21 instruments were
developed to be used across a broad spectrum of dis-
eases rather than validated for a specific disease. Some
other questionnaires (14.0%, n = 15) were validated on
individuals with chronic pain where the pain could be
related or not to a specific location. Lastly, other se-
lected instruments were designed for specific patients
in various medical specialties (the most frequent spe-
cialty was cardiology, n = 16) (Fig. 2).
Targeted concepts of the 107 selected questionnaires
The 107 selected questionnaires were classified into five
groups. The first group was composed of 29 questionnaires
(27.1%) dealing with HRQOL or QOL concepts. The second
group (19 questionnaires, 17.8%) focused on more specific
PROMs concepts that were symptoms and functional sta-
tus. The 20 questionnaires (18.7%) of the third group were
developed to analyze concepts related to patient’s feelings
and attitudes about illness. The fourth group (19 question-
naires, 17.8%) evaluated concepts related to patient’s atti-
tudes about treatments or healthcare. And the last group
(20 questionnaires, 18.7%) gathered questionnaires that ex-
plored patients’ experience of treatments or healthcare.
Dimensions explored according to questionnaire targeted
concepts
Questionnaires assessing HRQOL or QOL (Fig. 3a)
The classification of each dimension of the 29 selected
questionnaires assessing HRQOL or QOL is shown in Add-
itional file 2. Authors often used the briefer and more com-
mon abbreviation QOL as a synonym for HRQOL which
was the most frequently explored concept in the selected
questionnaires (n = 25, 23.4%). Dimensions observed in
HRQOL questionnaires were mainly “physical” dimensions
Fig. 2 Targeted population of the 107 selected questionnaires. Chronic disease: questionnaires intended for patients with various chronic diseases;
Cardiovascular disease: chronic-venous-insufficiency, leg wound (with either venous or arterial ulcers), chronic-heart-failure, coronary-heart-disease,
hypertension, atrial-fibrillation; Chronic pain: according to the questionnaires: patients with pain at different sites (headache or facial pain,
musculoskeletal-pain, back or cervical pain, extremity pain, thoracic or abdominal pain, fibromyalgia…), specific or generalized, current continuous or
intermittent; Hepato-gastro-enterology: gastro-esophageal reflux, irritable bowel syndrome, chronic-diverticular-disease, constipation, chronic-liver-
disease, hepatic-encephalopathy; Pneumology: chronic respiratory disease, chronic obstructive pulmonary disease, asthma, chronic-cough; Neurology:
vertigo, epilepsy, stroke, multiple-sclerosis, amyotrophic lateral sclerosis, progressive-neuromuscular-disease, spinal-cord-injury, Parkinson’s
disease; Dermatology: chronic skin disorders, psoriasis, eczema, urticaria, ichthyoses, seborrheic dermatitis, lichen planus, chronic oral
mucosal condition, recurrent aphthous stomatitis, vesiculobullous conditions (mucous membrane pemphigoid and pemphigus vulgaris),
granulomatosis, recurrent genital herpes; Rheumatology/Orthopaedics: chronic-rheumatic-diseases, rheumatoid-arthritis, shoulder-problem,
chronic-whiplash-associated-disorders; Nephrology/ Urology: chronic kidney diseases, hemodialysis, chronic-prostatis, intermittent-self-
catheterization; Internal medicine: lupus, sarcoidosis, chronic-fatigue, syncope; Oncology: various kinds of cancers, chronic radiation
patients; Hematology: sickle-cell-disease, chronic graft-versus-host disease; Infectious diseases: human immunodeficiency virus (HIV);
Endocrinology: diabetes, thyroïd-eye-disease; Otorhinolaryngology: chronic otitis media, chronic-nasal-dysfunction;
Ophtalmology: glaucoma
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(physical symptoms, pain…), “psychological” dimensions
(depression, anxiety, mood, emotions…), “social” dimensions
(social activities, work, leisure, relationship, family, friends,
community, social support, environment, isolation, financial
status…), and “functional” dimensions (impact of symp-
toms, disability, patient’s autonomy and limitations to
realize activities of daily living: food, sleep, memory, concen-
tration, sexual disorders, emotional and social function-
ing…) [15–28]. Most questionnaires were structured using
these four dimension categories, even if this categorization
was not always explicitly defined [29–32]. If some authors
agreed that a disease affects patients in a multidimensional
manner, others argued that all dimensions cannot be
covered exhaustively by a short and useful instrument
[33]. In some instances, some aspects of health related
quality of life were considered particularly important
[23, 34, 35] and all dimensions were not explored.
Some authors tried to explore all HRQOL aspects in a
unique global HRQOL dimension [33, 36, 37] with the
goal to assess in itself broader concepts like “overall
quality of life” [34] or “general health” [20]. This kind
of dimensions has been gathered in a new category
called “global dimensions”. Health status was also a
concept sometimes mistakenly interchanged with
HRQOL or QOL. Four questionnaires presented health
status as the main explored concept [38–41]. Health
status instruments more likely measure deviations from
a state of health, or from the absence of illness and disease
[42]. However in this review, one health status instrument
also contains a “QOL” dimension [41]. Lastly, two instru-
ments were divided arbitrarily in two distinct dimensions,
each evaluating HRQOL and symptoms [43, 44].
Fig. 3 Dimensions explored according to questionnaires targeted concepts: a HRQOL or QOL, b Functional status or symptoms, c Feelings and
attitudes about illness, d Attitudes about treatments or healthcare, e Experience of treatments or healthcare. This figure represents each
dimension category and its mapping to the concept(s) to visualize which categories of dimensions were the most explored according to
questionnaires targeted concepts. For example, on (a), 86% of the selected HRQOL or QOL instruments explored a physical dimension, 69%
explored a functional dimension, 76% explored a social dimension and 69% explored a psychological dimension. HRQOL: Health-Related Quality
Of Life, QOL: Quality Of Life
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Questionnaires assessing functional status or symptoms
(Fig. 3b)
Nineteen questionnaires were designed specifically to focus
on symptoms and/or on functional status. The classifica-
tion of each dimension of these questionnaires is shown in
Additional file 3. Eight questionnaires (6.5%) were con-
structed to explore symptoms (symptom burden, frequency,
severity, duration, pain, lack of energy…) [45–52]. Nine
questionnaires (8,4%) explored functional status (mobility,
impairment, daily, household activities…) [53–61].
The co-evaluation of “Functional” and “physical” di-
mensions was frequent within these questionnaires and
2 instruments were designed to explore both symptoms
and functional status simultaneously [62, 63].
Questionnaires assessing patient’s feelings and attitudes
about illness (Fig. 3c)
The classification of each dimension of the 20 question-
naires assessing patient’s attitudes about illness is shown in
Additional file 4. These questionnaires contained predom-
inantly two kinds of dimensions. On one hand, dimensions
that were termed “illness perceptions” dimensions explored
patients’ experience of illness [64], patients’ spirituality
[65], worries or concerns about recurrence [66], health re-
lated hardiness [67], patient’s discomfort [68], patient’s bur-
den [69], patients’ feelings of being a burden to their
caregivers [70], or social impact and stigma induced by the
disease [71].
On the other hand, dimensions that were termed “illness
behaviour and coping” dimensions assessed patients’ atti-
tude about illness [72–74], patients’ cognition [75, 76],
acceptance of chronic health condition [77] and patients’
attitudes of coping [78–81]. These two categories of di-
mensions seemed inextricably linked and in some ques-
tionnaires both patient’s feelings about the disease and
capacity to overcome this difficult life event were explored
simultaneously [82]. This is exemplified in the Well-being
in Wounds Inventory [83], composed of two dimensions:
the ‘Wound worries’ dimension which reflects “a person’s
cognitive responses to having a wound”; and the ‘Personal
resources’ dimension which described “a set of positive be-
haviors (such as hope, optimism, and coping), which have
been linked to personality traits”.
Questionnaires assessing patient’s attitudes about
treatments or healthcare (Fig. 3d)
The classification of each dimension of the 19 ques-
tionnaires assessing patient’s attitudes about treat-
ments or healthcare is shown in Additional file 5.
Three kinds of questionnaires were obtained, each
composed of different kinds of dimensions that formed
three new categories of dimensions.
To begin, 8 questionnaires were composed of dimen-
sions related to patient’s “beliefs and adherence to
treatment”, assessing patient’s adherence [84, 85], pa-
tient’s beliefs about treatment [86] and factors that in-
fluence patient’s adherence to treatment [87–91].
Next, 4 questionnaires contained dimensions more
related to “patients’ knowledge”, assessing patient’s
misconceptions [92], knowledge about illness, lifestyle,
treatment management or monitoring [93], skill and
technique acquisition, health services navigation [94],
allowed and recommended activities, entitlements, so-
cial and health care support [95].
Lastly, some dimensions were more related to patient
“involvement in healthcare”. These dimensions dealing
with individuals perception of their ability to reduce or
manage symptoms and to their autonomy in self-care were
mainly assessed in 7 questionnaires which focused on dif-
ferent concepts that were considered close enough to be
merged (“patient activation” [96], “patients’ engagement”
[97], “self-efficacy” [98], “self-management” [99], “self-care”
[100]). Support for disease self-management (from family
and friends, as well as support received from health care
resources or workplace, media, public policy, neighbor-
hood and community) [101] or potential barriers to
self-management (like comorbidities, healthcare system
and providers communication…) [102] were also some-
times evaluated in these instruments. Questionnaires con-
taining these three new categories of dimensions relating
to patient’s “beliefs and adherence to treatment”, “patients’
knowledge”, and patient’s “involvement in healthcare” were
collected together since all of them seemed strongly
linked, and dealt with patient’s knowledge and attitudes
about treatments or healthcare.
Questionnaires assessing patient’s experience of treatments
or healthcare (Fig. 3e)
The classification of each dimension of the 20 question-
naires related to patient’s experience of treatments or
healthcare system is shown in Additional file 6.
Questionnaires about patient’s experience of
treatment 12 questionnaires explored patient’s experi-
ence of treatment. Two categories of dimensions were
found in these questionnaires.
Firstly, those which focused on patients’ “expectations
and satisfaction with treatment” [103–108], exploring for
example patients’ preferences [109] or treatment conveni-
ence of use [105, 110, 111], and secondly, those which fo-
cused on “effects of treatment” taking into consideration
effectiveness [103, 105, 109], side effects [105, 107, 110],
time to recover from treatment [112], level of expressed
needs [113], treatment burden [114], and impact of treat-
ment on health related quality of life [107] or on psycho-
logical well-being [111]. These two kinds of dimensions
were often used conjointly in these instruments.
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Questionnaires about patient’s experience of health
care Eight instruments contained dimensions that focused
on patient’s experience of health care. These dimensions
often focused on treatment staff communication [115, 116]
(with one questionnaire specifically designed to explore pa-
tients’ communication preferences [117]) and also explored
interaction with the physician [118], confidence and trust,
and patients’ opinion about a physicians competency [115,
116]. Other dimensions more related to the healthcare sys-
tem organization focused on delivered information, plan of
care, link to community resources, care transitions [119],
treatment planning [120], care coordination [121] and
home care [122].
Questionnaires targeted concepts into the twelve final
categories of dimensions (Fig. 4)
Nearly half of the selected scales were designed to explore
patients’ QOL, HRQOL, health status, functional status or
symptoms. As a consequence, the most frequently explored
dimensions in selected questionnaires were “functional”,
“physical”, “psychological” and “social” dimensions. Patients’
“illness perceptions” was also a category of dimensions often
explored and mainly assessed in two kinds of instruments:
naturally in questionnaires specifically designed to explore
patient’s feelings and attitude about illness in which “illness
behaviors and coping” dimensions were jointly explored
and unexpectedly in HRQOL instruments. Similarly, “effects
of treatment” dimensions were logically present in specific
questionnaires exploring patient’s experience of treatments
or healthcare with “expectations and satisfaction with treat-
ment” and “experience of healthcare” dimensions but also
in HRQOL instruments. To finish, “beliefs and adherence to
treatment”, “patients’ knowledge” and “involvement in
health care” categories of dimensions where mainly ex-
plored in specific questionnaires focusing on patients’ atti-
tudes about treatments or healthcare.
Discussion
One hundred and seven primary PRM validation studies
from 1980 to 2016 were selected. All selected instruments
exploring patient experience of chronic disease or health-
care were gathered into five clusters: 1) Questionnaires ex-
ploring patients’ HRQOL or QOL; 2) Questionnaires
focusing on symptoms and functional status; 3) Question-
naires assessing patient’s feelings and attitudes about ill-
ness; 4) Questionnaires assessing patients’ attitudes about
treatments or healthcare; 5) Questionnaires related to pa-
tient’s experience of treatments or healthcare. After the
classification of all dimensions, 12 categories were retained:
the seven pre-defined categories (“physical”, “psychological”,
“social”, “functional”, “effects of treatment”, “expectations
and satisfaction with treatment”, and “experience of health-
care” dimensions) to which were added five new categories
of dimensions (“illness perceptions”, “illness behaviors and
coping”, “beliefs and adherence to treatment”, “patients’
knowledge”, and “involvement in health care” dimensions).
To summarize, the twelve final categories of dimensions
could be classified into three groups: the first one related to
patient reported impact of illness on his/her life (with “func-
tional”, “physical”, “psychological”, “social” dimensions); the
second one more related to patient evaluation and satisfac-
tion with treatment and healthcare (including “Experience
of healthcare”, “Effects of treatment” and “expectations and
satisfaction with treatment” dimensions); and a third one
more related to patient’s adaptation to illness and treatment
(with “illness perceptions”, “illness behaviors and coping”,
“beliefs and adherence to treatment”, “involvement in health
care” and “patients’ knowledge” dimensions). This represen-
tation seems to complete the Shale patient experience con-
cept [123], outlining three main domains including: the
illness experience (symptoms and illness consequences),
customer service experience, and the lived experience of
the illness (coping/dealing with the condition).
Fig. 4 Questionnaires targeted concepts occurrence into the twelve final categories of dimensions Among the questionnaires covering Physical
dimension, 25 were targeted HRQoL or QoL, 11 aimed to assess Functional status and Symptoms, 1 was targeted Patient’s feeling and attitudes
about illness and 2 were targeted Patient’s feeling and attitudes about treatments or healthcare. HRQOL: Health-Related Quality Of Life, QOL:
Quality Of Life
Forestier et al. Health and Quality of Life Outcomes           (2019) 17:19 Page 8 of 13
Inclusion of the “lived experience of the illness”
seems to be an important issue to understand chronic
patient experience. It has to be noted that in chronic ill-
ness, psychosocial adjustment to the disease might produce
psychopathological responses resulting in mood disorders,
anxiety, depression, and posttraumatic stress symptoms but
can also lead to a positive adaptation phenomenon like
increased ability to cope with tragedy, perceived benefits,
personal growth, improved relationships [124]. In fact, if
the negative aspects of changes can be assessed with the
dimensions captured by this review, no concepts or dimen-
sions focused on positive psychological change experienced
by chronic patients and could be interesting to assess.
The majority of the selected questionnaires in the re-
view were HRQOL instruments but the selected articles
often used the terms HRQOL, QOL and health status
interchangeably. If health is one of the important QOL
domains, other important domains must be taken into
account, and aspects of culture, values, and spirituality
add to the complexity of QOL measurement [125]. Des-
pite the increasing interest in QOL, consensus is lacking
on its measurement, which could appear too broad to al-
ways be considered appropriate for the medical field.
Furthermore, the terms QOL, HRQOL and health status
were also often used interchangeably in the literature
[126–130], even if QOL and health status are two related,
but distinct concepts [131]. Thus, the coexistence of dif-
ferent conceptualizations or designation of the same con-
cept is a major problem because comparability between
certain tools may come into question. An unclear concep-
tual match between a PRM instrument and an intended
claim may result in problems with analysis and interpret-
ation of study data [132].
It has to be noted that some questionnaires mixed
subjective and more factual dimensions. For example,
“Effects of treatment” (including treatment outcomes
and side effects) and “expectations and satisfaction with
treatment” dimensions were sometimes explored inside
the same questionnaires. However, it is important to
keep in mind that these two categories of dimensions
don’t explore the same domains. So if these two kinds
of dimensions are interesting to evaluate, they can’t be
interpreted in the same way. Given the great variety of
concepts and dimensions obtained in the review, the
development of an instrument exploring all chronic pa-
tient experience domains appears inappropriate. It is
therefore highly recommended for researchers to focus
on specific domains they are interested in, to clearly de-
fine them before any instrument development and to
not encompass them in broader concepts.
For reasons of comprehension, only articles written in
English or French were retained during this review and for
practical reasons only three databases were searched in this
study. Whilst they were of course relevant, articles in other
languages cannot be evaluated. The two most frequent lan-
guages in which relevant articles were excluded were Ger-
man (61 questionnaires) and Spanish (12 questionnaires).
Then, the search equation was built including the most
well-known kinds of PRMs concepts in the medical litera-
ture and did not cover all PRMs concepts. These could
contribute to a selection bias. Indeed, many selected ques-
tionnaires were QOL or HRQOL instruments. However,
QOL and HRQOL are probably the oldest and most famil-
iar PRM concepts studied in the literature (the PRO term
only appeared in 1999 [133], while articles of the review
were collected since 1980). Furthermore, a wide range of
PRM was captured, used for a wide range of chronic pa-
tients and designed to explore many different concepts,
even if some of them were not explicitly mentioned in the
search equation (like patient activation concept for ex-
ample). This diversity in captured questionnaires was ra-
ther reassuring and covered all concepts listed by the
Cochrane Handbook for Systematic Reviews of Interven-
tions mentioning that PROMs: “may include the signs and
symptoms reported in diaries, the evaluation of sensations
(most commonly classified as symptoms), reports of be-
haviors and abilities (most commonly classified as func-
tional status), general perceptions or feelings of well-being,
and other reports including satisfaction with treatment,
general or health-related quality of life, and adherence to
treatments. Reports may also include adverse or side ef-
fects” [1].
Within this study many choices were made and could be
discussed. Indeed, some diseases or symptoms (e.g. syn-
cope) could be classified into different medical specialties
and many pathological clusters could be discussed. In the
same way, if most HRQOL instruments have mainly fo-
cused on physical, psychological and social functioning, un-
fortunately, all these dimensions were not always clearly
defined and easy to classify since many dimensions simul-
taneously explored several domains (like the “social and
emotional” dimension [30] for example). As a consequence,
many dimensions were classified inside different categories.
“Illness perceptions” dimensions and “psychological” dimen-
sions were also sometimes hard to distinguish. Indeed,
“worry” or “concerns” dimensions could be considered as
“psychological” dimensions. However, since they dealt more
with patient subjective perception than with psychological
health status, these dimensions were clustered into the pa-
tients’ “illness perceptions” category of dimensions.
PRM for psychiatric patients were not considered in this
review because the assumption was made that the experi-
ence of patients with chronic psychiatric disorders might
differ from other chronic patients. There has been extensive
evidence published demonstrating the consistency of psy-
chiatric patients’ reports about their inner feelings [134],
psychiatric patient experience could be interesting to ex-
plore and could be the subject of future focused research.
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Conclusion
Patient experience in chronic illness needs to be conceptu-
ally defined before it can be accurately measured. This re-
view listed many concepts and dimensions that could be
used to assess some aspects of chronic patient experience.
A great diversity in PRMs exists for chronic patients and
none of the reviewed and selected questionnaires covered
all identified categories of dimensions. Categories of
dimensions that were retained concerned both patient’s
personal experience and attitude about illness, treatment
or healthcare. It appears that the definition of concepts
used varied widely among researchers and some concepts
were often confusing as they are used interchangeably.
These terms, similar to the many-facetted “patient experi-
ence” expression, should be well-defined before any in-
strument development or PRMs interpretation. Before
attempting to measure the chronic patient experience, re-
searchers should perhaps construct instruments relying
on strong definition of concepts and dimensions encom-
passing a patient’s personal experience and attitude to ill-
ness, treatment or healthcare and possibly consider a
patient’s positive adaptation to correctly measure changes
in their experience of chronic disease.
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